The use of SGLT2 inhibitors vs DDP-4 inhibitors is associated with a reduced risk of developing different types of dementia.

Study results published in Pediatric Rheumatology suggest that maintaining sufficient serum 25 (OH)-vitamin D levels could positively influence Kawasaki disease outcomes.

Risk factors for DKA, CKD, and hypertension included COVID-19 infection among patients with type 1 diabetes regardless of hospitalization.

The guidance on existing tools for obesity management can help clinicians treat patients with or at risk for chronic kidney disease (CKD).

The FDA has granted Orphan Drug designation to LQT-1213, a serum glucocorticoid regulated kinase 1 inhibitor, for long QT syndrome.

Black patients are more likely to experience prolonged onset to arrival intervals and decreased odds of EMS prenotification in stroke.

The FDA has cleared the Hearing Aid Feature, the first OTC hearing aid software intended for use with compatible versions of the AirPods Pro.

Shift work was associated with an increased risk for circadian syndrome but not metabolic syndrome among adults, especially those with evening work.

Tirzepatide for diabetes vs long-acting insulins demonstrated superior glycemic control and weight loss compared among adults with type 2 diabetes.

Current INSTI vs protease inhibitor or NNRTI use is linked to an increased risk for diabetes, which is slightly attenuated when adjusted for changes in BMI.

Sex hormone binding globulin changes were mediated by waist circumference among patients with type 2 diabetes receiving lifestyle intervention.

Paternal HBV infection prior to pregnancy may be associated with increased CHD risk in offspring, according to results of a large matched cohort study.